Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 4735-4740, October 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abdel Malek, Z. A.
Right arrow Articles by Wilkes, B. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abdel Malek, Z. A.
Right arrow Articles by Wilkes, B. C.

Prolonged Stimulation of S91 Melanoma Tyrosinase by [Nle4,D-Phe7]-substituted {alpha}-Melanotropins1

Zalfa A. Abdel Malek, Kristie L. Kreutzfeld, Mohamed M. Marwan, Mac E. Hadley2, Victor J. Hruby and Brian C. Wilkes

Departments of Anatomy and Molecular and Cellular Biology, University of Arizona, Tucson, Arizona 85724 [Z. A. A. M., K. L. K., M. M. M., M. E. H.], and Department of Chemistry, University of Arizona, Tucson, Arizona 85721 [V. J. H., B. C. W.]

{alpha}-Melanotropin ({alpha}-melanocyte stimulating hormone, {alpha}-MSH) stimulates tyrosinase activity in Cloudman S91 murine melanoma cells. Three [Nle4, D-Phe7]-substituted {alpha}-melanotropin analogues, [Nle4,D-Phe7]-{alpha}-MSH, Ac-[Nle4,D-Phe7]-{alpha}-MSH4–11-NH2, and Ac-[Nle4,D-Phe7]-{alpha}-MSH4–10-NH2, are at least 100-fold more effective than {alpha}-MSH in stimulating melanoma tyrosinase, the rate-limiting enzyme in melanin biosynthesis. These [Nle4,D-Phe7]-substituted melanotropin analogues induce tyrosinase activity in melanoma cells with shorter contact times than required by the native hormone, {alpha}-MSH. [Nle4,D-Phe7]-substituted melanotropins also induce a prolonged (residual) stimulation of melanoma tyrosinase. Following incubation of melanoma cells in the presence of [Nle4,D-Phe7]-{alpha}-MSH for 24 h, tyrosinase activity is maintained for up to 6 days in the absence of the melanotropin. The shorter 4–10 and 4–11 fragment analogues also exhibit residual melanotropic activity. The prolonged stimulation of tyrosinase in the absence of the analogues is maintained even though melanoma cells continue to divide about every 24 h. These results suggest that melanoma cells possess spare melanotropin receptors and that [Nle4, D-Phe7]-substituted analogues bind almost irreversibly to these receptors or to some other component of the adenylate cyclase enzyme complex responsible for enhancing tyrosinase activity and melanin production.

1 The work was supported in part by USPHS grant AM 17420 and by National Science Foundation Grants PCM-8412084 and PCM-8100708.

2 To whom requests for reprints should be addressed, at Department of Anatomy, Arizona Health Sciences Center, University of Arizona, Tucson, AZ 85724.

Received 3/13/85. Revised 7/ 2/85. Accepted 7/ 5/85.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Pavey and B. Gabrielli
{alpha}-Melanocyte Stimulating Hormone Potentiates p16/CDKN2A Expression in Human Skin after Ultraviolet Irradiation
Cancer Res., February 1, 2002; 62(3): 875 - 880.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.